Cite
MLA Citation
William Nigel Patton et al.. “An open-label, single-arm, phase 1 study to assess biomarker effects, efficacy and safety of ofatumumab in patients with refractory chronic lymphocytic leukemia.” Leukemia & lymphoma, vol. 56, no. 10, n.d., pp. 2819–2825. http://access.bl.uk/ark:/81055/vdc_100089569349.0x000023